Helus Pharma Inc 6-K, filed Oct 5, 2026
Helus Pharma Inc. (HELP)
About this 6-K
Helus Pharma Inc filed this 6-K on October 5, 2026.
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Form 6-K
REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16
UNDER THE SECURITIES EXCHANGE ACT OF 1934
For the month of October, 2026.
Commission File Number: 001-40673
Helus Pharma Inc.
(Exact Name of Registrant as Specified in Charter)
100 King Street West, Suite 5600, Toronto, Ontario, M5X 1C9
(Address of principal executive offices)
Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F.
Form 20-F □ Form 40-F ⊠
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
| HELUS PHARMA INC. | |||
| (Registrant) | |||
| Date: | October 5, 2026 | By: | /s/ Greg Cavers |
| Name: | Greg Cavers | ||
| Title: | Chief Financial Officer | ||
EXHIBIT INDEX
| 99.1 | Certificate and Articles of Amendment |
